Caris Life Sciences, Inc. (CAI)
27.23
+1.10
(+4.21%)
USD |
NASDAQ |
Aug 25, 11:46
Caris Life Sciences Price : 27.23 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 25.84 | 26.66 | 25.40 | 26.13 | 5.804M |
| Aug 21, 2026 | 24.73 | 26.60 | 24.32 | 26.27 | 6.389M |
| Aug 20, 2026 | 22.59 | 24.76 | 22.59 | 24.58 | 6.033M |
| Aug 19, 2026 | 21.92 | 22.94 | 21.92 | 22.76 | 6.559M |
| Aug 18, 2026 | 21.31 | 21.64 | 20.78 | 20.97 | 3.598M |
| Aug 17, 2026 | 22.00 | 22.19 | 21.52 | 21.63 | 2.772M |
| Aug 14, 2026 | 22.26 | 22.43 | 21.44 | 21.80 | 3.869M |
| Aug 13, 2026 | 22.84 | 23.12 | 22.14 | 22.18 | 2.973M |
| Aug 12, 2026 | 22.90 | 22.96 | 21.99 | 22.26 | 4.025M |
| Aug 11, 2026 | 23.39 | 23.66 | 22.99 | 23.14 | 6.044M |
| Aug 10, 2026 | 22.68 | 23.44 | 22.68 | 23.40 | 5.912M |
| Aug 07, 2026 | 20.70 | 22.77 | 20.12 | 22.74 | 9.402M |
| Aug 06, 2026 | 19.00 | 20.11 | 17.94 | 20.00 | 11.27M |
| Aug 05, 2026 | 16.03 | 16.54 | 15.96 | 16.45 | 6.766M |
| Aug 04, 2026 | 16.26 | 16.55 | 15.91 | 16.10 | 4.845M |
| Aug 03, 2026 | 15.92 | 16.59 | 15.84 | 16.32 | 4.902M |
| Jul 31, 2026 | 16.05 | 16.14 | 15.23 | 15.67 | 3.511M |
| Jul 30, 2026 | 15.58 | 16.17 | 15.46 | 16.09 | 4.543M |
| Jul 29, 2026 | 15.43 | 16.00 | 15.26 | 15.59 | 5.625M |
| Jul 28, 2026 | 15.74 | 16.03 | 15.41 | 15.59 | 3.620M |
| Jul 27, 2026 | 15.69 | 16.02 | 15.46 | 15.63 | 3.455M |
| Jul 24, 2026 | 15.74 | 15.94 | 15.18 | 15.52 | 4.932M |
| Jul 23, 2026 | 15.20 | 16.20 | 15.11 | 15.65 | 2.541M |
| Jul 22, 2026 | 15.61 | 15.84 | 15.29 | 15.38 | 1.991M |
| Jul 21, 2026 | 15.50 | 16.06 | 15.13 | 15.73 | 3.189M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CareDx, Inc. | 49.64 |
| Myriad Genetics, Inc. | 3.12 |
| BioRestorative Therapies, Inc. | 0.22 |
| Natera, Inc. | 333.40 |
| Exagen, Inc. | 7.68 |
Price Related Metrics
| PE Ratio | 73.14 |
| PS Ratio | 7.774 |
| Price to Book Value | 13.00 |
| Price to Free Cash Flow | 66.18 |
| Earnings Yield | 1.37% |
| Market Cap | 7.695B |
| Operating PE Ratio | 50.20 |
| Normalized PE Ratio | 61.23 |